Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 19, 2025 09:00 ET | Source: Centre C3i Inc.

Le Centre C3i, une compagnie canadienne, reçoit l'approbation de l’EMA pour fabriquer des produits de thérapie cellulaire pour le marché européen

C3i reçoit une certification de conformité aux Bonnes pratiques de fabrications (BPF) par l'Agence européenne des medicaments (EMA)
February 19, 2025 09:00 ET | Source: Centre C3i Inc.

C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market

C3i receives a certificate of Good Manufacturing Practice (GMP) compliance by the European Medicines Agency (EMA).
December 16, 2021 09:30 ET | Source: Centre C3i Inc.

AstraZeneca supports the growth of the C3i Lymphoma Registry, a project led by Dr. Isabelle Fleury at Hôpital Maisonneuve-Rosemont

MONTREAL, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The C3i Center (C3i) is proud to announce the participation of AstraZeneca Canada (AstraZeneca) in supporting the development of the Lymphoma Registry....
December 16, 2021 09:29 ET | Source: Centre C3i Inc.

AstraZeneca soutient la croissance du Registre de lymphomes de C3i, un projet dirigé par Dre Isabelle Fleury à l'Hôpital Maisonneuve-Rosemont

MONTRÉAL, 16 déc. 2021 (GLOBE NEWSWIRE) -- Le Centre C3i (C3i) est fier d'annoncer la participation d'AstraZeneca Canada (AstraZeneca) pour soutenir le développement du Registre de...
November 09, 2021 10:00 ET | Source: Centre C3i Inc.

C3i Center Inc. Secures CAP Accreditation, Launches New Lab Spinoff

MONTRÉAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- C3i Center Inc. has strengthened our position as Canada’s leading one-stop contract development and manufacturing organization operating in the cell...